- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/70 - One oxygen atom
Patent holdings for IPC class C07D 233/70
Total number of patents in this class: 127
10-year publication summary
|
7
|
8
|
12
|
9
|
13
|
13
|
9
|
5
|
4
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 408 |
8 |
| The Regents of the University of California | 20690 |
6 |
| Buck Institute for Research on Aging | 129 |
6 |
| Theravance, Inc. | 61 |
6 |
| The Regents of the University of Michigan | 4964 |
3 |
| Cornell University | 3418 |
3 |
| Pliant Therapeutics, Inc. | 66 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 854 |
3 |
| Epivario Inc. | 6 |
3 |
| F. Hoffmann-La Roche AG | 7832 |
2 |
| Hoffmann-La Roche Inc. | 3773 |
2 |
| Centre National de La Recherche Scientifique | 10993 |
2 |
| Bayer AG | 3488 |
2 |
| FUJIFILM Corporation | 30458 |
2 |
| President and Fellows of Harvard College | 6078 |
2 |
| CHDI Foundation, Inc. | 106 |
2 |
| Neuropore Therapies, Inc. | 31 |
2 |
| Shikoku Chemicals Corporation | 104 |
2 |
| Universite D'orleans | 130 |
2 |
| Migal Galilee Research Institute Ltd. | 52 |
2 |
| Other owners | 64 |